We are live on ! Find out more
EAM

Empery Asset Management Portfolio holdings

AUM $86.5M
This Fund
S&P 500
This Quarter Est. Return
-34.27%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.5M
AUM Growth
-$2.81M
Cap. Flow
+$6.2M
Cap. Flow %
33.6%
Top 10 Hldgs %
79.94%
Holding
88
New
11
Increased
–
Reduced
13
Closed
13
Avg Time Held
1.5 quarters
Top 10 Avg Time Held
0.8 quarters
Top 20 Avg Time Held
0.8 quarters

Top Buys

Rank Stock Value
1
MMAT icon
Meta Materials Inc. Common Stock
MMAT
+$6.52M
2
SLS icon
SELLAS Life Sciences
SLS
+$2.72M
3
ETNB icon
89bio
ETNB
+$1.21M
4
APLT icon
Applied Therapeutics
APLT
+$1.11M
5
SKYAW icon
SkyAI Inc
SKYAW
+$343K

Top Sells

Rank Stock Value
1
BRCC.WS icon
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
+$1.2M
2
SBFM icon
Sunshine Biopharma
SBFM
+$1.1M
3
VLNS
The Valens Company, Inc. Common Shares
VLNS
+$688K
4
AIOS icon
AIOS Tech
AIOS
+$658K
5
STLN icon
Starling Oncology
STLN
+$504K

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.77%
2 Healthcare 25.83%
3 Technology 25.02%
4 Consumer Staples 0.38%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MMAT icon
1
DELISTED
Meta Materials Inc. Common Stock
MMAT
$4.5M 24.38%
+43,706
New +$6.52M
2022 Q2
0 quarters
POL.WS
2
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$2.08M 11.25%
7,985,355
-310,000
-4% -$133K
2021 Q4
2 quarters
SLS icon
3
SELLAS Life Sciences
SLS
$2.41B
$2.07M 11.2%
+927,984
New +$2.72M
2022 Q2
0 quarters
ETNB icon
4
DELISTED
89bio
ETNB
$1.29M 6.98%
+400,000
New +$1.21M
2022 Q2
0 quarters
FATBW
5
DELISTED
FAT Brands Inc. Warrant
FATBW
$1.2M 6.48%
281,598
– –
2021 Q4
2 quarters
HCDIZ
6
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$1.1M 5.95%
2,930,730
– –
2021 Q4
2 quarters
SRZN icon
7
Surrozen
SRZN
$276M
$773K 4.19%
17,184
-5,080
-23% -$208K
2021 Q4
2 quarters
APLT icon
8
DELISTED
Applied Therapeutics
APLT
$640K 3.47%
+675,000
New +$1.11M
2022 Q2
0 quarters
TCBPW
9
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$571K 3.09%
2,823,528
– –
2022 Q1
1 quarter
HGTY.WS icon
10
DELISTED
Hagerty, Inc. Warrants, each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share
HGTY.WS
$545K 2.95%
178,758
– –
2021 Q4
2 quarters
NTRBW icon
11
DELISTED
Nutriband Inc Warrant
NTRBW
$438K 2.37%
76,604
– –
2021 Q4
2 quarters
SURGW icon
12
DELISTED
SurgePays, Inc. Warrant
SURGW
$344K 1.86%
286,495
– –
2021 Q4
2 quarters
ZEV.WS
13
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
$284K 1.54%
676,381
– –
2021 Q4
2 quarters
SKYAW icon
14
SkyAI Inc
SKYAW
$705K
$231K 1.25%
+829,851
New +$343K
2022 Q2
0 quarters
PEPLW
15
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$189K 1.02%
740,000
-2,500
-0.3% -$1.02K
2021 Q4
2 quarters
ARBEW icon
16
DELISTED
Arbe Robotics Warrant
ARBEW
$138K 0.75%
189,904
– –
2021 Q4
2 quarters
CINGW icon
17
Cingulate Inc Warrants
CINGW
$10.7K
$118K 0.64%
500,000
– –
2021 Q4
2 quarters
SVRE icon
18
SaverOne 2014 Ltd
SVRE
$2.77M
$118K 0.64%
+6
New +$131K
2022 Q2
0 quarters
DRCTW icon
19
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
$105K 0.57%
270,000
– –
2022 Q1
1 quarter
MTEKW icon
20
Maris-Tech Ltd Warrants
MTEKW
$97K 0.53%
297,600
– –
2022 Q1
1 quarter
LEXXW icon
21
DELISTED
Lexaria Bioscience Warrant
LEXXW
$88K 0.48%
126,215
-4,467
-3% -$3.91K
2021 Q4
2 quarters
NRSNW icon
22
NeuroSense Therapeutics Warrant
NRSNW
$235K
$82K 0.44%
160,000
– –
2021 Q4
2 quarters
BNCWW icon
23
BNB Standard Corporation Warrant
BNCWW
$77K 0.42%
500,000
– –
2022 Q1
1 quarter
REED icon
24
DELISTED
Reeds, Inc. Common Stock
REED
$71K 0.38%
9,129
-18,871
-67% -$206K
2022 Q1
1 quarter
SVREW icon
25
SaverOne 2014 Ltd Warrant
SVREW
$64K 0.35%
+181,500
New +$72.4K
2022 Q2
0 quarters
1
2 3 4

Similar funds

BCM
Beaumont Capital Management Boston, Massachusetts $86.4M AUM 20.04% 1-Year Est. Return
TI
Truxt Investmentos Rio De Janeiro, Brazil $86.6M AUM
LCM
LDR Capital Management New York $86.7M AUM 16.32% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $86.7M AUM
RCSA
REYL & Cie S.A. Geneva, Switzerland $86.7M AUM
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
CL
CPWA LLC Hood River, Oregon $86.1M AUM
TWM
Tripletail Wealth Management Orlando, Florida $86.9M AUM 39.01% 1-Year Est. Return

Empery Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Empery Asset Management held 88 positions worth $18.5M, down 13% from $21.3M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Empery Asset Management deployed $6.2M of net new capital in Q2 2022, opening 11 new positions. Its largest new stake was Meta Materials Inc. Common Stock: 43,706 shares worth $4.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 75% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Sunshine Biopharma Inc Warrant, an estimated $389K trimmed.

  • Empery Asset Management's largest Q2 2022 buy was Meta Materials Inc. Common Stock: 43,706 shares worth $4.5M.
  • Empery Asset Management's biggest Q2 2022 reduction was Sunshine Biopharma Inc Warrant, cutting an estimated $389K.
  • Empery Asset Management fully exited BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a in Q2 2022, selling an estimated $1.2M.
  • Empery Asset Management's ten largest holdings make up 80% of its $18.5M portfolio in Q2 2022.
  • Empery Asset Management opened 11 new positions and closed 13 in Q2 2022.
  • Empery Asset Management's portfolio value fell 13% quarter-over-quarter to $18.5M.

Based on Empery Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.